By proceeding, you agree to our Terms of Use and Privacy Policy.
Dr. Blanchard most recently served as chief scientific officer at a subsidiary of Innovent Biologics, Inc. (HKEX: 1801), from January 2018 to June 2019.
Talks About #development #cellcycleregulation #epigenetics
Preferred Locations #EastAsia
For seven years, the China Healthcare Summit has been building the “Bridge to Innovation” in China.
